In Re: National Prescription Opiate Litigation

Track this case

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

November 07, 2019
Sparks Fly In Opioid MDL As Judge, Attys Debate Next Trials

The Ohio federal judge supervising multidistrict opioid litigation has warned attorneys for local governments and drug companies that he will unilaterally select future bellwether trials unless they quickly do so themselves, according to a meeting transcript obtained Thursday by Law360.
November 05, 2019
Opioid MDL Judge Draws Fresh Fire From Pharmacies

The Ohio federal judge overseeing multidistrict opioid litigation appears to have decided key issues about the MDL's future without first accepting input from pharmacy defendants, according to their strongly worded court filing late Tuesday.
October 31, 2019
Opioid MDL Attys Poised To Debate Next Bellwether Trials

Attorneys in the opioid multidistrict litigation are gearing up for a closed-door debate next week over future bellwether trials, a showdown that will closely follow settlements that canceled the MDL's first trial.
October 21, 2019
$48B Opioid Deal Outcry May Presage Plaintiff Infighting

A rapid outburst of opposition to a $48 billion "settlement framework" in opioid-crisis litigation unveiled Monday by four state attorneys general may signal a shift to local governments and states fighting not only with drug companies but also with each other.
October 21, 2019
State AGs Reach $48B Proposed Deal To End Opioid Cases

Four attorneys general on Monday unveiled a proposed $48 billion deal with major drug companies — Teva Pharmaceuticals, Johnson & Johnson and the nation's largest drug distributors — to resolve a wave of opioid-crisis lawsuits.
October 21, 2019
Opioid Trial Halted By Drug Cos.' 11th Hour $260M Deal

Two Ohio counties on Monday reached a deal worth $260 million with some of the nation's largest drug companies to avoid the first trial in opioid multidistrict litigation.
October 17, 2019
What To Watch As Opioid MDL Nears Moment Of Truth

Amid whirlwind settlement talks, nationwide litigation over the pharmaceutical industry’s alleged role in the opioid crisis is on the cusp of a historic trial. Here, Law360 looks at settlement prospects and key issues if the epic courtroom showdown proceeds.
October 16, 2019
Drug Cos. Float Deals Worth $50B To End Opioid Cases

Major drug manufacturers and distributors — including Johnson & Johnson and McKesson — are proposing deals that could be worth a combined $50 billion to resolve large portions of nationwide litigation over pharmaceutical industry liability for the opioid crisis, a source with direct knowledge of the offers told Law360 on Wednesday.
October 10, 2019
Ohio Trial In Opioid MDL Will Go Forward, 6th Circ. Says

The Sixth Circuit on Thursday rejected eleventh-hour bids by the Ohio attorney general and drug companies to block an upcoming bellwether trial in multidistrict litigation accusing drugmakers of fueling the opioid crisis, rejecting the state's arguments that the counties in the case are usurping its authority.
October 08, 2019
Questions Swirl Around Opioid MDL Bellwether Trial

A highly anticipated bellwether trial in the opioid multidistrict litigation is increasingly shrouded in uncertainty amid a flurry of settlements with drugmakers and aggressive maneuvers by drug distributors to avoid going before a jury.

← Previous
…
29
30
31
32
33
34
35
36
37
…
Next →